
Noble E. Jarrell
Examiner (ID: 12009)
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1624, 1609, 1622, 1625, 1699 |
| Total Applications | 1399 |
| Issued Applications | 944 |
| Pending Applications | 168 |
| Abandoned Applications | 328 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19411714
[patent_doc_number] => 12077519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Heteroaryl carboxamide compound
[patent_app_type] => utility
[patent_app_number] => 18/521400
[patent_app_country] => US
[patent_app_date] => 2023-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22707
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18521400
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/521400 | Heteroaryl carboxamide compound | Nov 27, 2023 | Issued |
Array
(
[id] => 19097707
[patent_doc_number] => 20240116935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => DIACYLGLYCEROL KINASE (DGK) ALPHA INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/507595
[patent_app_country] => US
[patent_app_date] => 2023-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18507595
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/507595 | Diacylglycerol kinase (DGK) alpha inhibitors and uses thereof | Nov 12, 2023 | Issued |
Array
(
[id] => 19027252
[patent_doc_number] => 11926599
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-03-12
[patent_title] => 1-(2-chlorobenzylideneamino)-5,5-diphenylimidazolidine-2,4-dione as an antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/382819
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3981
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18382819
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/382819 | 1-(2-chlorobenzylideneamino)-5,5-diphenylimidazolidine-2,4-dione as an antimicrobial compound | Oct 22, 2023 | Issued |
Array
(
[id] => 19210653
[patent_doc_number] => 11999701
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-06-04
[patent_title] => 4,5-bis(4-chlorophenyl)-2-phenyl-1H-imidazol-1-yl as an antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/382972
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4210
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18382972
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/382972 | 4,5-bis(4-chlorophenyl)-2-phenyl-1H-imidazol-1-yl as an antimicrobial compound | Oct 22, 2023 | Issued |
Array
(
[id] => 18964100
[patent_doc_number] => 11897850
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-02-13
[patent_title] => N'-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-4-methoxybenzimidamide as an antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/484734
[patent_app_country] => US
[patent_app_date] => 2023-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3893
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18484734
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/484734 | N'-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-4-methoxybenzimidamide as an antimicrobial compound | Oct 10, 2023 | Issued |
Array
(
[id] => 20187055
[patent_doc_number] => 12398160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Cot modulators and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/374108
[patent_app_country] => US
[patent_app_date] => 2023-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24264
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18374108
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/374108 | Cot modulators and methods of use thereof | Sep 27, 2023 | Issued |
Array
(
[id] => 20187055
[patent_doc_number] => 12398160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Cot modulators and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/374108
[patent_app_country] => US
[patent_app_date] => 2023-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24264
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18374108
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/374108 | Cot modulators and methods of use thereof | Sep 27, 2023 | Issued |
Array
(
[id] => 18806990
[patent_doc_number] => 20230381323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => RELEASABLE CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 18/234142
[patent_app_country] => US
[patent_app_date] => 2023-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 319
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18234142
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/234142 | RELEASABLE CONJUGATES | Aug 14, 2023 | Pending |
Array
(
[id] => 20356186
[patent_doc_number] => 12472165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Riluzole prodrugs and their use
[patent_app_type] => utility
[patent_app_number] => 18/361838
[patent_app_country] => US
[patent_app_date] => 2023-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 38606
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361838
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/361838 | Riluzole prodrugs and their use | Jul 28, 2023 | Issued |
Array
(
[id] => 18806816
[patent_doc_number] => 20230381149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => RILUZOLE PRODRUGS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/361837
[patent_app_country] => US
[patent_app_date] => 2023-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361837
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/361837 | Riluzole prodrugs and their use | Jul 28, 2023 | Issued |
Array
(
[id] => 18674979
[patent_doc_number] => 20230312502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => METHODS TO PURIFY CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 18/328547
[patent_app_country] => US
[patent_app_date] => 2023-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18328547
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/328547 | METHODS TO PURIFY CANNABINOIDS | Jun 1, 2023 | Pending |
Array
(
[id] => 19065600
[patent_doc_number] => 20240100026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH
[patent_app_type] => utility
[patent_app_number] => 18/196106
[patent_app_country] => US
[patent_app_date] => 2023-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18196106
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/196106 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH | May 10, 2023 | Abandoned |
Array
(
[id] => 19050783
[patent_doc_number] => 20240092752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => GAS PHASE METHODS TO DECARBOXYLATE CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 18/309646
[patent_app_country] => US
[patent_app_date] => 2023-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18309646
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/309646 | GAS PHASE METHODS TO DECARBOXYLATE CANNABINOIDS | Apr 27, 2023 | Pending |
Array
(
[id] => 19172424
[patent_doc_number] => 20240158398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
[patent_app_type] => utility
[patent_app_number] => 18/137228
[patent_app_country] => US
[patent_app_date] => 2023-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18137228
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/137228 | INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE | Apr 19, 2023 | Pending |
Array
(
[id] => 18537438
[patent_doc_number] => 20230242530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => 8-(AZETIDIN-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/297546
[patent_app_country] => US
[patent_app_date] => 2023-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 267
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18297546
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/297546 | 8-(AZETIDIN-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | Apr 6, 2023 | Pending |
Array
(
[id] => 18524289
[patent_doc_number] => 20230234946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/296018
[patent_app_country] => US
[patent_app_date] => 2023-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296018
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296018 | COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME | Apr 4, 2023 | Pending |
Array
(
[id] => 18628092
[patent_doc_number] => 20230286917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => HISTONE DEMETHYLASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/126327
[patent_app_country] => US
[patent_app_date] => 2023-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18126327
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/126327 | HISTONE DEMETHYLASE INHIBITORS | Mar 23, 2023 | Pending |
Array
(
[id] => 19186208
[patent_doc_number] => 20240165121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => SUBSTITUTED BENZENE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/188700
[patent_app_country] => US
[patent_app_date] => 2023-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188700
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/188700 | SUBSTITUTED BENZENE COMPOUNDS | Mar 22, 2023 | Pending |
Array
(
[id] => 18649324
[patent_doc_number] => 20230295113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => NLRP3 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 18/183856
[patent_app_country] => US
[patent_app_date] => 2023-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18183856
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/183856 | NLRP3 MODULATORS | Mar 13, 2023 | Pending |
Array
(
[id] => 18649324
[patent_doc_number] => 20230295113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => NLRP3 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 18/183856
[patent_app_country] => US
[patent_app_date] => 2023-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18183856
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/183856 | NLRP3 MODULATORS | Mar 13, 2023 | Pending |